India CDMO Market 2033

India CDMO Market Size, Share, Trends and Forecast by Service Type, Type, Scale of Operation, Therapeutic Area, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A30719

Buy Now Discount
Offer

India CDMO Market Overview:

The India CDMO market size reached USD 7.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.7% during 2025-2033. The market is experiencing robust growth, principally influenced by the increasing demand for contract manufacturing services in pharmaceuticals, particularly for complex generics, HPAPIs, and sterile injectables. With a strong regulatory framework and associated cost advantages, Indian CDMOs are expanding their global footprint, catering to markets like the U.S., Europe, and emerging economies, thereby creating a positive market outlook.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 7.9 Billion
Market Forecast in 2033	USD 15.4 Billion
Market Growth Rate 2025-2033	7.7%

India CDMO Market Trends:

Expansion of Biologics and Biosimilars Manufacturing

The contract development and manufacturing organization (CDMO) market in India is witnessing strong growth due to the rising demand for biologics and biosimilars. As global pharmaceutical companies increasingly outsource biologic drug development and production, Indian CDMOs are investing in advanced biomanufacturing capabilities, including mammalian and microbial expression systems. The push for affordable biosimilars is driving partnerships between firms, positioning India as a key hub for cost-effective, high-quality biologics production. For instance, in December 2024, Mankind Pharma Ltd announced a strategic partnership with Innovent Biologics to license and commercialize Sintilimab in India, aiming to improve cancer treatment access by providing innovative immunotherapy solutions to address critical healthcare challenges in the region. Additionally, the expansion of state-of-the-art bioreactors, single-use technologies, and process optimization strategies is enhancing efficiency and scalability in biopharmaceutical manufacturing. Regulatory alignment with agencies like USFDA and EMA further strengthens India’s competitive advantage in contract manufacturing. As the demand for targeted therapies, monoclonal antibodies, and gene-based treatments rises, Indian CDMOs are expected to play a critical role in supplying global markets, ensuring cost efficiency while maintaining high regulatory and quality standards.

India CDMO Market Size

Increasing Demand for End-to-End CDMO Services

Pharmaceutical companies are increasingly seeking end-to-end services from CDMOs, covering drug discovery, formulation development, clinical trial support, commercial-scale production, and regulatory compliance. This trend is driven by the need for faster time-to-market, cost-efficiency, and streamlined supply chains. Indian CDMOs are expanding their capabilities to offer comprehensive solutions, enabling global drug developers to outsource the entire product lifecycle under a single contract. The integration of AI-driven drug discovery, process automation, and real-time data analytics is further enhancing efficiency in development and manufacturing. Additionally, CDMOs are focusing on high-potency active pharmaceutical ingredients (HPAPIs), complex generics, and sterile injectables, strengthening their position as strategic outsourcing partners. For instance, in January 2024, Aragen Life Sciences announced a substantial investment of INR 20 Billion (approximately US$230.5 Million) in Telangana to bolster its drug discovery, development, and manufacturing capabilities, reflecting a strategic focus on expanding complex generics and HPAPI production. In addition, government incentives for pharmaceutical innovation, regulatory harmonization, and infrastructure development are supporting this growth. With increasing investments in R&D facilities, analytical services, and quality control, Indian CDMOs are emerging as preferred partners for global pharmaceutical companies seeking cost-effective, high-quality solutions.

India CDMO Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on service type, type, scale of operation, and therapeutic area.

Service Type Insights:

Contract Development Services
- Preclinical Development
- Clinical Development
- Analytical and Bioanalytical Services

Contract Manufacturing Services
- Active Pharmaceutical Ingredients (APIs) Manufacturing
- Finished Dosage Forms (FDFs) Manufacturing
- Biologics Manufacturing
- Packaging

The report has provided a detailed breakup and analysis of the market based on the service type. This includes contract development services (preclinical development, clinical development, and analytical and bioanalytical services) and contract manufacturing services (active pharmaceutical ingredients (APIs) manufacturing, finished dosage forms (FDFs) manufacturing, biologics manufacturing, and packaging).

Type Insights:

Small Molecules
Biologics
Biosimilars
Vaccines
Others

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes small molecules, biologics, biosimilars, vaccines, and others.

Scale of Operation Insights:

Commercial Scale
Clinical Scale

The report has provided a detailed breakup and analysis of the market based on the scale of operation. This includes commercial scale and clinical scale.

Therapeutic Area Insights:

Oncology
Cardiovascular Diseases
Infectious Diseases
Central Nervous System (CNS) Disorders
Others

A detailed breakup and analysis of the market based on the therapeutic area have also been provided in the report. This includes oncology, cardiovascular diseases, infectious diseases, central nervous system (CNS) disorders, and others.

Regional Insights:

North India
South India
East India
West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India CDMO Market News:

In December 2024, Akums Drugs and Pharmaceuticals Limited announced a partnership with a notable global pharma company to serve as a CDMO, manufacturing and supplying oral liquid formulations for the European market. The agreement, valued at Euro 200 million, will begin in 2027, with approvals anticipated by 2026.

India CDMO Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Service Type Type Scale of Operation Therapeutic Area Region
Service Types Covered	Contract Development Services: Preclinical Development, Clinical Development, Analytical and Bioanalytical Services Contract Manufacturing Services: Active Pharmaceutical Ingredients (APIs) Manufacturing, Finished Dosage Forms (FDFs) Manufacturing, Biologics Manufacturing, Packaging
Types Covered	Small Molecules, Biologics, Biosimilars, Vaccines, Others
Scale of Operations Covered	Commercial Scale, Clinical Scale
Therapeutic Areas Covered	Oncology, Cardiovascular Diseases, Infectious Diseases, Central Nervous System (CNS) Disorders, Others
Regions Covered	North India, South India, East India, West India
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India CDMO market performed so far and how will it perform in the coming years?
What is the breakup of the India CDMO market on the basis of service type?
What is the breakup of the India CDMO market on the basis of type?
What is the breakup of the India CDMO market on the basis of scale of operation?
What is the breakup of the India CDMO market on the basis of therapeutic area?
What is the breakup of the India CDMO market on the basis of region?
What are the various stages in the value chain of the India CDMO market?
What are the key driving factors and challenges in the India CDMO market?
What is the structure of the India CDMO market and who are the key players?
What is the degree of competition in the India CDMO market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India CDMO market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the India CDMO market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India CDMO industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.